354 related articles for article (PubMed ID: 30386679)
1. Tumor mutational burden is a determinant of immune-mediated survival in breast cancer.
Thomas A; Routh ED; Pullikuth A; Jin G; Su J; Chou JW; Hoadley KA; Print C; Knowlton N; Black MA; Demaria S; Wang E; Bedognetti D; Jones WD; Mehta GA; Gatza ML; Perou CM; Page DB; Triozzi P; Miller LD
Oncoimmunology; 2018; 7(10):e1490854. PubMed ID: 30386679
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic T-lymphocyte infiltration and chemokine predict long-term patient survival independently of tumor mutational burden in triple-negative breast cancer.
Katsuta E; Yan L; Opyrchal M; Kalinski P; Takabe K
Ther Adv Med Oncol; 2021; 13():17588359211006680. PubMed ID: 33868461
[TBL] [Abstract][Full Text] [Related]
3. Association Between Genomic Metrics and Immune Infiltration in Triple-Negative Breast Cancer.
Karn T; Jiang T; Hatzis C; Sänger N; El-Balat A; Rody A; Holtrich U; Becker S; Bianchini G; Pusztai L
JAMA Oncol; 2017 Dec; 3(12):1707-1711. PubMed ID: 28750120
[TBL] [Abstract][Full Text] [Related]
4. ADRB1 was identified as a potential biomarker for breast cancer by the co-analysis of tumor mutational burden and immune infiltration.
Wang J; Zhang X; Li J; Ma X; Feng F; Liu L; Wu J; Sun C
Aging (Albany NY); 2020 Nov; 13(1):351-363. PubMed ID: 33234738
[TBL] [Abstract][Full Text] [Related]
5. Tumor mutational and indel burden: a systematic pan-cancer evaluation as prognostic biomarkers.
Wu HX; Wang ZX; Zhao Q; Chen DL; He MM; Yang LP; Wang YN; Jin Y; Ren C; Luo HY; Wang ZQ; Wang F
Ann Transl Med; 2019 Nov; 7(22):640. PubMed ID: 31930041
[TBL] [Abstract][Full Text] [Related]
6. Mining The Cancer Genome Atlas database for tumor mutation burden and its clinical implications in gastric cancer.
Zhao DY; Sun XZ; Yao SK
World J Gastrointest Oncol; 2021 Jan; 13(1):37-57. PubMed ID: 33510848
[TBL] [Abstract][Full Text] [Related]
7. Interactions between tumor mutation burden and immune infiltration in ovarian cancer.
Mi JL; Xu M; Liu C; Wang RS
Int J Clin Exp Pathol; 2020; 13(10):2513-2523. PubMed ID: 33165430
[TBL] [Abstract][Full Text] [Related]
8. Multiomics analysis of tumor mutational burden across cancer types.
Li L; Bai L; Lin H; Dong L; Zhang R; Cheng X; Liu Z; Ouyang Y; Ding K
Comput Struct Biotechnol J; 2021; 19():5637-5646. PubMed ID: 34745455
[TBL] [Abstract][Full Text] [Related]
9. Interference of tumour mutational burden with outcome of patients with head and neck cancer treated with definitive chemoradiation: a multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group.
Eder T; Hess AK; Konschak R; Stromberger C; Jöhrens K; Fleischer V; Hummel M; Balermpas P; von der Grün J; Linge A; Lohaus F; Krause M; Baumann M; Stuschke M; Zips D; Grosu AL; Abdollahi A; Debus J; Belka C; Pigorsch S; Combs SE; Budach V; Tinhofer I;
Eur J Cancer; 2019 Jul; 116():67-76. PubMed ID: 31173964
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Role of Tumor Mutation Burden Combined With Immune Infiltrates in Skin Cutaneous Melanoma Based on Multi-Omics Analysis.
Yan J; Wu X; Yu J; Zhu Y; Cang S
Front Oncol; 2020; 10():570654. PubMed ID: 33240814
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Frequently Mutated Cancer Genes and Tumor Mutation Burden in Chinese Breast Cancer.
Xiao W; Zhang G; Chen B; Chen X; Wen L; Lai J; Li X; Li M; Liu H; Liu J; Han-Zhang H; Lizaso A; Liao N
Front Oncol; 2021; 11():618767. PubMed ID: 33968723
[TBL] [Abstract][Full Text] [Related]
12. Prognostic analysis of patients with breast cancer based on tumor mutational burden and DNA damage repair genes.
Teng X; Yang T; Yuan B; Yang Y; Liu J; Wang X; Wang Y; Ma T; Yin X; Yu H; Wang S; Huang W
Front Oncol; 2023; 13():1177133. PubMed ID: 37350936
[TBL] [Abstract][Full Text] [Related]
13. Integrated Analysis of Copy Number Variation, Microsatellite Instability, and Tumor Mutation Burden Identifies an 11-Gene Signature Predicting Survival in Breast Cancer.
Jin X; Yan J; Chen C; Chen Y; Huang WK
Front Cell Dev Biol; 2021; 9():721505. PubMed ID: 34650974
[TBL] [Abstract][Full Text] [Related]
14. Immune and Stroma Related Genes in Breast Cancer: A Comprehensive Analysis of Tumor Microenvironment Based on the Cancer Genome Atlas (TCGA) Database.
Xu M; Li Y; Li W; Zhao Q; Zhang Q; Le K; Huang Z; Yi P
Front Med (Lausanne); 2020; 7():64. PubMed ID: 32195260
[No Abstract] [Full Text] [Related]
15. Tumor mutation burden, immune checkpoint crosstalk and radiosensitivity in single-cell RNA sequencing data of breast cancer.
Jang BS; Han W; Kim IA
Radiother Oncol; 2020 Jan; 142():202-209. PubMed ID: 31767471
[TBL] [Abstract][Full Text] [Related]
16. The Tumor Mutational Burden of Chinese Advanced Cancer Patients Estimated by a 381-cancer-gene Panel.
Zhuang W; Ma J; Chen X; Wang G; Lu J; Chen Y; Dong H; Cai S; Zhang Y; Zhao X; Zhu Y; Xu C; Huang Y; Huang Z; Zhu X; Jiang H; Wang Z
J Cancer; 2018; 9(13):2302-2307. PubMed ID: 30026825
[No Abstract] [Full Text] [Related]
17. Clinical Implications of Circulating Tumor DNA Tumor Mutational Burden (ctDNA TMB) in Non-Small Cell Lung Cancer.
Chae YK; Davis AA; Agte S; Pan A; Simon NI; Iams WT; Cruz MR; Tamragouri K; Rhee K; Mohindra N; Villaflor V; Park W; Lopes G; Giles FJ
Oncologist; 2019 Jun; 24(6):820-828. PubMed ID: 30867242
[TBL] [Abstract][Full Text] [Related]
18. Tumor mutational burden and driver mutations: Characterizing the genomic landscape of pediatric brain tumors.
Patel RR; Ramkissoon SH; Ross J; Weintraub L
Pediatr Blood Cancer; 2020 Jul; 67(7):e28338. PubMed ID: 32386112
[TBL] [Abstract][Full Text] [Related]
19. Impact of high tumor mutational burden in solid tumors and challenges for biomarker application.
McNamara MG; Jacobs T; Lamarca A; Hubner RA; Valle JW; Amir E
Cancer Treat Rev; 2020 Sep; 89():102084. PubMed ID: 32738738
[TBL] [Abstract][Full Text] [Related]
20. An immune-centric exploration of BRCA1 and BRCA2 germline mutation related breast and ovarian cancers.
Przybytkowski E; Davis T; Hosny A; Eismann J; Matulonis UA; Wulf GM; Nabavi S
BMC Cancer; 2020 Mar; 20(1):197. PubMed ID: 32164626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]